Fig. 5

MKI67 expression levels in liver hepatocellular carcinoma. a MKI67 expression in TISIDB-derived LIHC having diverse molecular subtypes; b MKI67 expression in TISIDB-derived LIHC having diverse immune subtypes; c MKI67 expression in GEPIA-derived LIHC of diverse stages (MKI67 gene levels were calculated relative to the log counts per million mapped reads (log2CPM) in (a, b) and log2(TPM + 1) in (c); d immunohistochemistry (IHC) for MKI67 based on the HPA database; e MKI67 level related to PR/ER status and sample type. T: Protein levels of MKI67 in tumor tissue (staining: high; intensity: strong, quantity: 75–25%) https://www.proteinatlas.org/ENSG00000148773-MKI67/pathology/liver+cancer#img; N: Protein levels of MKI67 in normal tissue (staining: Not detected; intensity: weak, quantity: < 25%) https://www.proteinatlas.org/ENSG00000148773-MKI67/tissue/liver#img